TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Sznol, M. AU - Postow, M. A. AU - Davies, M. J. AU - Pavlick, A. C. AU - Plimack, E. R. AU - Shaheen, M. AU - Veloski, C. AU - Robert, C. PY - 2017 DA - 2017// TI - Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management JO - Cancer Treat Rev VL - 58 UR - https://doi.org/10.1016/j.ctrv.2017.06.002 DO - 10.1016/j.ctrv.2017.06.002 ID - Sznol2017 ER - TY - JOUR AU - de Filette, J. AU - Jansen, Y. AU - Schreuer, M. AU - Everaert, H. AU - Velkeniers, B. AU - Neyns, B. AU - Bravenboer, B. PY - 2016 DA - 2016// TI - Incidence of thyroid-related adverse events in melanoma patients treated with pembrolizumab JO - J Clin Endocrinol Metab VL - 101 UR - https://doi.org/10.1210/jc.2016-2300 DO - 10.1210/jc.2016-2300 ID - de Filette2016 ER - TY - JOUR AU - Orlov, S. AU - Salari, F. AU - Kashat, L. AU - Walfish, P. G. PY - 2015 DA - 2015// TI - Induction of painless thyroiditis in patients receiving programmed death 1 receptor immunotherapy for metastatic malignancies JO - J Clin Endocrinol Metab VL - 100 UR - https://doi.org/10.1210/jc.2014-4560 DO - 10.1210/jc.2014-4560 ID - Orlov2015 ER - TY - JOUR AU - Scott, L. J. PY - 2015 DA - 2015// TI - Nivolumab: a review in advanced melanoma JO - Drugs VL - 75 UR - https://doi.org/10.1007/s40265-015-0442-6 DO - 10.1007/s40265-015-0442-6 ID - Scott2015 ER - TY - JOUR AU - Borghaei, H. AU - Paz-Ares, L. AU - Horn, L. AU - Spigel, D. R. AU - Steins, M. AU - Ready, N. E. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1507643 DO - 10.1056/NEJMoa1507643 ID - Borghaei2015 ER - TY - JOUR AU - Greef, B. AU - Eisen, T. PY - 2016 DA - 2016// TI - Medical treatment of renal cancer: new horizons JO - Br J Cancer VL - 115 UR - https://doi.org/10.1038/bjc.2016.230 DO - 10.1038/bjc.2016.230 ID - Greef2016 ER - TY - JOUR AU - Okano, Y. AU - Satoh, T. AU - Horiguchi, K. AU - Toyoda, M. AU - Osaki, A. AU - Matsumoto, S. PY - 2016 DA - 2016// TI - Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma JO - Endocr J VL - 63 UR - https://doi.org/10.1507/endocrj.EJ16-0161 DO - 10.1507/endocrj.EJ16-0161 ID - Okano2016 ER - TY - JOUR AU - Kitajima, K. AU - Ashida, K. AU - Wada, N. AU - Suetsugu, R. AU - Takeichi, Y. AU - Sakamoto, S. PY - 2017 DA - 2017// TI - Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab JO - Jpn J Clin Oncol VL - 47 UR - https://doi.org/10.1093/jjco/hyx018 DO - 10.1093/jjco/hyx018 ID - Kitajima2017 ER - TY - JOUR AU - Weber, J. S. AU - Hodi, F. S. AU - Wolchok, J. D. AU - Topalian, S. L. AU - Schadendorf, D. AU - Larkin, J. PY - 2017 DA - 2017// TI - Safety profile of Nivolumab Monotherapy: a pooled analysis of patients with advanced melanoma JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2015.66.1389 DO - 10.1200/JCO.2015.66.1389 ID - Weber2017 ER - TY - JOUR AU - Robert, C. AU - Long, G. V. AU - Brady, B. AU - Dutriaux, C. AU - Maio, M. AU - Mortier, L. PY - 2015 DA - 2015// TI - Nivolumab in previously untreated melanoma without BRAF mutation JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1412082 DO - 10.1056/NEJMoa1412082 ID - Robert2015 ER - TY - STD TI - National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). Version 4.03. Quick Reference. https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Published June 14 (2010). Accessed 14 Aug 2017. UR - https://www.eortc.be/services/doc/ctc/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf ID - ref12 ER - TY - BOOK PY - 2010 DA - 2010// TI - AJCC Cancer staging manual PB - Dordrecht, Heidelberg, London: Springer CY - New York UR - https://doi.org/10.1007/978-0-387-88441-7 DO - 10.1007/978-0-387-88441-7 ID - ref13 ER - TY - JOUR AU - Tanaka, R. AU - Fujisawa, Y. AU - Maruyama, H. AU - Nakamura, Y. AU - Yoshino, K. AU - Ohtsuka, M. AU - Fujimoto, M. PY - 2016 DA - 2016// TI - Nivolumab-induced thyroid dysfunction JO - Jpn J Clin Oncol VL - 46 UR - https://doi.org/10.1093/jjco/hyw036 DO - 10.1093/jjco/hyw036 ID - Tanaka2016 ER - TY - JOUR AU - Yamauchi, I. AU - Sakane, Y. AU - Fukuda, Y. AU - Fujii, T. AU - Taura, D. AU - Hirata, M. PY - 2017 DA - 2017// TI - Clinical features of Nivolumab-induced thyroiditis.: a case series study JO - Thyroid VL - 27 UR - https://doi.org/10.1089/thy.2016.0562 DO - 10.1089/thy.2016.0562 ID - Yamauchi2017 ER - TY - JOUR AU - Huber, G. AU - Staub, J. J. AU - Meier, C. AU - Mitrache, C. AU - Guglielmetti, M. AU - Huber, P. AU - Braverman, L. E. PY - 2002 DA - 2002// TI - Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies JO - J Clin Endocrinol Metab VL - 87 UR - https://doi.org/10.1210/jcem.87.7.8678 DO - 10.1210/jcem.87.7.8678 ID - Huber2002 ER - TY - JOUR AU - Yoshida, H. AU - Amino, N. AU - Yagawa, K. AU - Uemura, K. AU - Satoh, M. AU - Miyai, K. AU - Kumahara, Y. PY - 1978 DA - 1978// TI - Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases JO - J Clin Endocrinol Metab VL - 46 UR - https://doi.org/10.1210/jcem-46-6-859 DO - 10.1210/jcem-46-6-859 ID - Yoshida1978 ER - TY - JOUR AU - Kahaly, G. J. PY - 2015 DA - 2015// TI - Bioassays for TSH receptor antibodies: quo Vadis? JO - Eur Thyroid J VL - 4 UR - https://doi.org/10.1159/000375445 DO - 10.1159/000375445 ID - Kahaly2015 ER - TY - JOUR AU - Zöphel, K. AU - Roggenbuck, D. AU - Schott, M. PY - 2010 DA - 2010// TI - Clinical review about TRAb assay's history JO - Autoimmun Rev VL - 9 UR - https://doi.org/10.1016/j.autrev.2010.05.021 DO - 10.1016/j.autrev.2010.05.021 ID - Zöphel2010 ER - TY - JOUR AU - McLachlan, S. M. AU - Rapoport, B. PY - 2013 DA - 2013// TI - Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa JO - Thyroid VL - 23 UR - https://doi.org/10.1089/thy.2012.0374 DO - 10.1089/thy.2012.0374 ID - McLachlan2013 ER - TY - JOUR AU - Weber, J. AU - Thompson, J. A. AU - Hamid, O. AU - Minor, D. AU - Amin, A. AU - Ron, I. PY - 2009 DA - 2009// TI - A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-1024 DO - 10.1158/1078-0432.CCR-09-1024 ID - Weber2009 ER - TY - JOUR AU - Attia, P. AU - Phan, G. Q. AU - Maker, A. V. AU - Robinson, M. R. AU - Quezado, M. M. AU - Yang, J. C. PY - 2005 DA - 2005// TI - Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.06.205 DO - 10.1200/JCO.2005.06.205 ID - Attia2005 ER - TY - JOUR AU - Lee, H. J. AU - Li, C. W. AU - Hammerstad, S. S. AU - Stefan, M. AU - Tomer, Y. PY - 2015 DA - 2015// TI - Immunogenetics of autoimmune thyroid diseases: a comprehensive review JO - J Autoimmun VL - 64 UR - https://doi.org/10.1016/j.jaut.2015.07.009 DO - 10.1016/j.jaut.2015.07.009 ID - Lee2015 ER - TY - JOUR AU - Yagi, H. AU - Nomura, T. AU - Nakamura, K. AU - Yamazaki, S. AU - Kitawaki, T. AU - Hori, S. PY - 2004 DA - 2004// TI - Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells JO - Int Immunol VL - 16 UR - https://doi.org/10.1093/intimm/dxh165 DO - 10.1093/intimm/dxh165 ID - Yagi2004 ER - TY - JOUR AU - Okumura, A. AU - Ishikawa, T. AU - Sato, S. AU - Yamauchi, T. AU - Oshima, H. AU - Ohashi, T. PY - 2008 DA - 2008// TI - Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4(+) CD25(+) T cells in patients with autoimmune hepatitis JO - Hepatol Res VL - 3 UR - https://doi.org/10.1111/j.1872-034X.2008.00349.x DO - 10.1111/j.1872-034X.2008.00349.x ID - Okumura2008 ER - TY - JOUR AU - Ban, Y. AU - Tozaki, T. AU - Tobe, T. AU - Ban, Y. AU - Jacobson, E. M. AU - Concepcion, E. S. AU - Tomer, Y. PY - 2007 DA - 2007// TI - The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts JO - J Autoimmun VL - 28 UR - https://doi.org/10.1016/j.jaut.2007.02.016 DO - 10.1016/j.jaut.2007.02.016 ID - Ban2007 ER - TY - JOUR AU - Inoue, N. AU - Watanabe, M. AU - Morita, M. AU - Tomizawa, R. AU - Akamizu, T. AU - Hidaka, Y. AU - Iwatani, Y. PY - 2010 DA - 2010// TI - Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases JO - Clin Exp Immunol VL - 162 UR - https://doi.org/10.1111/j.1365-2249.2010.04229.x DO - 10.1111/j.1365-2249.2010.04229.x ID - Inoue2010 ER - TY - JOUR AU - Zhang, B. AU - Chikuma, S. AU - Hori, S. AU - Fagarasan, S. AU - Honjo, T. PY - 2016 DA - 2016// TI - Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model JO - Proc Natl Acad Sci U S A VL - 113 UR - https://doi.org/10.1073/pnas.1608873113 DO - 10.1073/pnas.1608873113 ID - Zhang2016 ER - TY - JOUR AU - McLeod, D. S. AU - Caturegli, P. AU - Cooper, D. S. AU - Matos, P. G. AU - Hutfless, S. PY - 2014 DA - 2014// TI - Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel JO - JAMA VL - 311 UR - https://doi.org/10.1001/jama.2013.285606 DO - 10.1001/jama.2013.285606 ID - McLeod2014 ER - TY - JOUR AU - Phenekos, C. AU - Vryonidou, A. AU - Gritzapis, A. D. AU - Baxevanis, C. N. AU - Goula, M. AU - Papamichail, M. PY - 2004 DA - 2004// TI - Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves’ disease (Th2) JO - Neuroimmunomodulation VL - 11 UR - https://doi.org/10.1159/000078438 DO - 10.1159/000078438 ID - Phenekos2004 ER - TY - JOUR AU - Dulos, J. AU - Carven, G. J. AU - van Boxtel, S. J. AU - Evers, S. AU - Driessen-Engels, L. J. AU - Hobo, W. PY - 2012 DA - 2012// TI - PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer JO - J Immunother VL - 35 UR - https://doi.org/10.1097/CJI.0b013e318247a4e7 DO - 10.1097/CJI.0b013e318247a4e7 ID - Dulos2012 ER -